The body mass index (BMI) may be associated with an increased incidence and aggressiveness of urological cancers. In this study, we aimed to evaluate the impact of the BMI on survival in patients with T1G3 non-muscle-invasive bladder cancer (NMIBC).

An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer

Ferro, Matteo;Terracciano, Daniela;Musi, Gennaro;Cioffi, Antonio;Grimaldi, Giovanni;Verze, Paolo;Autorino, Riccardo;Damiano, Rocco;Mirone, Vincenzo;Lucarelli, Giuseppe
2019

Abstract

The body mass index (BMI) may be associated with an increased incidence and aggressiveness of urological cancers. In this study, we aimed to evaluate the impact of the BMI on survival in patients with T1G3 non-muscle-invasive bladder cancer (NMIBC).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/720714
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 62
social impact